Topical ketorolac tromethamine , 0.45 % , significantly lowered aqueous IL-8 levels and vitreous IL-8 and PDGF-AA levels in this series of eyes , suggesting that it may cause meaningful inhibition of inflammatory cytokines implicated in the pathogenesis of DR.